Synthesis, central nervous system activity and structure–activity relationship of N-substituted derivatives of 1-arylimidazolidyn-2-ylideneurea and products of their cyclization

References

• Manjiani D, Paul DB, Kunnumpurath S, et al. Availability and utilization of opioids for pain management: global issues. Ochsner J 2014;14:208–15
   PubMedGoogle Scholar
• Rzadkowska M, Szacon E, Kaczor AA, et al. Synthesis, pharmacological activity and molecular modeling of 1-aryl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones and their 6-substituted derivatives. Med Chem 2014;10:460–75
   PubMed Web of Science ®Google Scholar
• Kaczor A, Matosiuk D. Non-peptide opioid receptor ligands – recent advances. Part I – agonists. Curr Med Chem 2002;9:1567–89
   PubMed Web of Science ®Google Scholar
• Kaczor A, Matosiuk D. Non-peptide opioid receptor ligands – recent advances. Part II – antagonists. Curr Med Chem 2002;9:1591–603
   PubMed Web of Science ®Google Scholar
• Huang P, Kim S, Loew G. Development of a common 3D pharmacophore for delta-opioid recognition from peptides and non-peptides using a novel computer program. J Comput Aided Mol Des 1997;11:21–8
   PubMed Web of Science ®Google Scholar
• Mosberg HI, Omnaas JR, Lomize A, et al. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). J Med Chem 1994;37:4384–91
   PubMed Web of Science ®Google Scholar
• Korlipara VL, Takemori AE, Portoghese PS. Electrophilic N-benzylnaltrindoles as delta opioid receptor-selective antagonists. J Med Chem 1995;38:1337–43
   PubMed Web of Science ®Google Scholar
• Matosiuk D, Fidecka S, Antkiewicz-Michaluk L, et al. Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine. Part 1. Synthesis and pharmacological activity of chain derivatives of 1-aryl-2-iminoimidazolidine containing urea moiety. Eur J Med Chem 2001;36:783–97
   PubMed Web of Science ®Google Scholar
• Matosiuk D, Fidecka S, Antkiewicz-Michaluk L, et al. Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine. Part 3. Synthesis and pharmacological activity of 1-aryl-5,6(1H)dioxo-2,3-dihydroimidazo[1,2-a]imidazoles. Eur J Med Chem 2002;37:845–53
   PubMed Web of Science ®Google Scholar
• Matosiuk D, Fidecka S, Antkiewicz-Michaluk L, et al. Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine: part 2. Synthesis and pharmacological activity of 1,6-diaryl-5,7(1H)dioxo-2,3-dihydroimidazo[1,2-a][1,3,5]triazines. Eur J Med Chem 2002;37:761–72
   PubMed Web of Science ®Google Scholar
• Sztanke K, Fidecka S, Kedzierska E, et al. Antinociceptive activity of new imidazolidine carbonyl derivatives. Part 4. Synthesis and pharmacological activity of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c] [1,2,4]triazines. Eur J Med Chem 2005;40:127–34
   PubMed Web of Science ®Google Scholar
• Rządkowska M, Szacoń E, Kaczor AA, et al. Synthesis, central nervous system activity, and structure–activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones. Med Chem Res 2014;10:460–75
   Web of Science ®Google Scholar
• Peckys D, Landwehrmeyer GB. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience 1999;88:1093–135
   PubMed Web of Science ®Google Scholar
• Sun H-L, Zheng J-W, Wang K, et al. Tramadol reduces the 5-HTP-induced head-twitch response in mice via the activation of mu and kappa opioid receptors. Life Sci 2003;72:1221–30
   PubMed Web of Science ®Google Scholar
• Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, eds. Textbook of pain. Edinburgh, London: Churchill Livingstone; 1994:243–57
   Google Scholar
• Pradhan AA, Smith ML, Zyuzin J, Charles A. δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice. Br J Pharmacol 2014;171:2375–84
   PubMed Web of Science ®Google Scholar
• Szacon E, Rzadkowska M, Matosiuk D, et al. Polish Patent PL 208539/2011
   Google Scholar
• Rzadkowska M, Szacon E, Matosiuk D, et al. Polish patent PL 211768/2012
   Google Scholar
• Rzadkowska M, Szacon E, Matosiuk D, et al. Polish patent PL 211769/2012
   Google Scholar
• Szacoń E, Rzadkowska M, Matosiuk D, et al. Polish patent PL 2138806/2013
   Google Scholar
• Bekircan O, Küxük M, Kahveci B, Kolayli S. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents. Arch Pharm (Weinheim) 2005;338:365–72
   PubMed Web of Science ®Google Scholar
• Saczewski F, Maruszak M, Bednarski PJ. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine. Arch Pharm (Weinheim) 2008;341:121–5
   PubMed Web of Science ®Google Scholar
• Soliman AM, Mohamed SK, El Remaily MAA, Abdel-Ghany H. Synthesis and biological activity of dihydroimidazole and 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazins. Eur J Med Chem 2012;47:138–42
   PubMed Web of Science ®Google Scholar
• LigPrep version 2.4. New York: Schrödinger, LLC; 2010
   Google Scholar
• Epik version 2.1. New York: Schrödinger, LLC; 2010
   Google Scholar
• Pedretti A, Villa L, Vistoli G. VEGA - an open platform to develop chemo-bio-informatic applications, using plug-in architecture and script” programming. J Comput Aided Mol Des 2004;18:167–73
   PubMed Web of Science ®Google Scholar
• Discovery Studio 3.1, Accelrys. Available from: http://accelrys.com [last accessed 15 Jun 2014]
   Google Scholar
• MOE Molecular Operating Environment (2009/2010), Chemical Computing Group. Available from: http://www.chemcomp.com/software.htm [last accessed 15 Jun 2014]
   Google Scholar
• Osiris Property Explorer. Available from: http://www.organic-chemistry.org/prog/peo/logS.html [last accessed 15 Jun 2014]
   Google Scholar
• Argus Lab, Available from: http://www.arguslab.com/arguslab.com/ArgusLab.html [last accessed 15 Jun 2014]
   Google Scholar
• Vogel GH, Vogel W. Drug discovery and evaluation. Pharmacological Assays. Berlin: Springer-Verlag, 1997
   Google Scholar
• Litchfield JT Jr, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99–113
   PubMed Web of Science ®Google Scholar
• Koster R, Anderson M, DeBeer EJ. Acetic acid for analgesic screening. Fed Proc 1959;18:412–16
   Google Scholar
• Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597–652
   PubMed Web of Science ®Google Scholar
• Gross F, Tripod J, Meir R. Zur Pharmakologischen charakterisierung des Schlafmittels. Doriden Schweiz Med Wochschr 1955;85:305–9
   PubMedGoogle Scholar
• Boissier JR, Tardy J, Diverres JC. Une nouvelle méthode simple pour explorer l’action tranquilisante: le test de la cheminée. Med Exp (Basel) 1960;3:81–4
   Google Scholar
• Corne SJ, Pickering RW, Warner BT. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol Chemother 1963;20:106–20
   PubMed Web of Science ®Google Scholar
• Lee SK, Chang GS, Lee IH, et al. The PreADME: pc-based program for batchprediction of ADMEproperties, In: EuroQSAR 2004, September, 5–10, Istanbul, Turkey
   Google Scholar
• Pajouhesh H, Lenz GR. Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2005;2:541–53
   PubMedGoogle Scholar
• Gutstein HB, Akil H. Opioid analgesics. In: Bruntn L, ed. Goodman and Gilman's. The pharmacological basis of therapeutics, 11th ed. New York: MacGrow Hill; 2006:547–90
   Google Scholar
• Cox B, Lomax P. Pharmacological studies on the central regulation of body temperature. Annu Rev Pharmacol Toxicol 1997;17:341–53
   Web of Science ®Google Scholar
• Gao B, Jr Ducan WC, Wehr TA. Clorgyline-induced reduction in body temperature and its relationship to vigilance states in Syrian hamsters. Neuropsychopharmacology 1991;4:187–97
   PubMed Web of Science ®Google Scholar
• Adell A, Bigg TA, Myers RD. Action of harman (1-methyl-β-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat. Neuropharmacology 1996;35:1101–7
   PubMed Web of Science ®Google Scholar